Feda H. Hamdan

971 total citations
25 papers, 507 citations indexed

About

Feda H. Hamdan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feda H. Hamdan has authored 25 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Feda H. Hamdan's work include Protein Degradation and Inhibitors (7 papers), Chromatin Remodeling and Cancer (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Feda H. Hamdan is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Chromatin Remodeling and Cancer (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Feda H. Hamdan collaborates with scholars based in United States, Germany and Spain. Feda H. Hamdan's co-authors include Steven A. Johnsen, Malek Zihlif, Ana P. Kutschat, Florian Wegwitz, Robyn Laura Kosinsky, Vijayalakshmi Kari, Vijay H. Shah, Nidhi Jalan‐Sakrikar, Robert C. Huebert and Jochen Gaedcke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Feda H. Hamdan

25 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feda H. Hamdan United States 16 326 146 103 56 54 25 507
Nicole P. Ho Hong Kong 6 265 0.8× 137 0.9× 213 2.1× 31 0.6× 65 1.2× 9 453
Ru Ji China 9 275 0.8× 185 1.3× 148 1.4× 100 1.8× 81 1.5× 18 552
Yong Gu China 10 324 1.0× 100 0.7× 181 1.8× 38 0.7× 51 0.9× 14 469
Byul A Jee South Korea 10 303 0.9× 59 0.4× 128 1.2× 59 1.1× 40 0.7× 10 445
Yu Yin China 13 329 1.0× 106 0.7× 254 2.5× 47 0.8× 35 0.6× 30 525
Zhuoying Lin China 9 215 0.7× 77 0.5× 91 0.9× 26 0.5× 71 1.3× 16 362
Veerabrahma Pratap Seshachalam Singapore 9 430 1.3× 100 0.7× 208 2.0× 36 0.6× 42 0.8× 12 657
Monica Aasrum Norway 16 241 0.7× 260 1.8× 96 0.9× 97 1.7× 84 1.6× 25 521
Tamer Yağcı Türkiye 13 357 1.1× 274 1.9× 162 1.6× 45 0.8× 38 0.7× 32 550
Haiyan Yue China 9 164 0.5× 87 0.6× 67 0.7× 72 1.3× 29 0.5× 12 327

Countries citing papers authored by Feda H. Hamdan

Since Specialization
Citations

This map shows the geographic impact of Feda H. Hamdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feda H. Hamdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feda H. Hamdan more than expected).

Fields of papers citing papers by Feda H. Hamdan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feda H. Hamdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feda H. Hamdan. The network helps show where Feda H. Hamdan may publish in the future.

Co-authorship network of co-authors of Feda H. Hamdan

This figure shows the co-authorship network connecting the top 25 collaborators of Feda H. Hamdan. A scholar is included among the top collaborators of Feda H. Hamdan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feda H. Hamdan. Feda H. Hamdan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nesvick, Cody L., Liang Zhang, Yuqian Yan, et al.. (2025). SWI/SNF complexes govern ontology-specific transcription factor function in MYC-subtype atypical teratoid rhabdoid tumor. Neuro-Oncology. 27(9). 2445–2460. 1 indexed citations
2.
Kosinsky, Robyn Laura, Dominik Saul, Luísa Leite Barros, et al.. (2024). The FOXP3+ Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn’s Disease. Gastroenterology. 166(4). 631–644.e17. 17 indexed citations
3.
Sun, Zhifu, Manuel B. Braga Neto, Yuning Xiong, et al.. (2023). Hypomethylation and Overexpression of Th17-Associated Genes is a Hallmark of Intestinal CD4+ Lymphocytes in Crohn’s Disease. Journal of Crohn s and Colitis. 17(11). 1847–1857. 3 indexed citations
4.
Hamdan, Feda H., et al.. (2023). Abstract 1481: MAPK and NF-kappaB signaling converge on the epigenome to transcriptionally activate genes involved in pancreatic cancer metastasis. Cancer Research. 83(7_Supplement). 1481–1481. 1 indexed citations
5.
Zhang, Zhe, Xin Wang, Feda H. Hamdan, et al.. (2023). NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming. Cellular and Molecular Gastroenterology and Hepatology. 15(5). 1219–1246. 3 indexed citations
6.
Zhang, Liang, Cody L. Nesvick, Charles Day, et al.. (2022). STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma. Neuro-Oncology. 24(10). 1700–1711. 19 indexed citations
7.
Jalan‐Sakrikar, Nidhi, Thiago M. de Assuncao, Feda H. Hamdan, et al.. (2021). Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation. Hepatology Communications. 6(2). 345–360. 18 indexed citations
8.
Kutschat, Ana P., Steven A. Johnsen, & Feda H. Hamdan. (2021). Store-Operated Calcium Entry: Shaping the Transcriptional and Epigenetic Landscape in Pancreatic Cancer. Cells. 10(5). 966–966. 5 indexed citations
9.
Bamidele, Adebowale O., Phyllis A. Svingen, Thomas C. Smyrk, et al.. (2021). BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease. Journal of Clinical Investigation. 131(12). 16 indexed citations
10.
Sehrawat, Tejasav S., Nidhi Jalan‐Sakrikar, Nicholas Pirius, et al.. (2021). Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complex. Journal of Hepatology. 76(4). 921–933. 30 indexed citations
11.
Kutschat, Ana P., Feda H. Hamdan, Xin Wang, et al.. (2021). STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer. Cancer Research. 81(11). 2943–2955. 11 indexed citations
12.
Wang, Xin, Ana P. Kutschat, Koji Tanaka, et al.. (2021). Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas. Cell Death and Differentiation. 28(7). 2207–2220. 21 indexed citations
13.
Wiese, Maria, Feda H. Hamdan, Gerrit H. Gielen, et al.. (2020). Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells. Cell Death and Disease. 11(8). 673–673. 44 indexed citations
14.
Aseem, Sayed Obaidullah, Nidhi Jalan‐Sakrikar, Cheng Chi, et al.. (2020). Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis. Gastroenterology. 160(3). 889–905.e10. 39 indexed citations
15.
Kari, Vijayalakshmi, Feda H. Hamdan, Jochen Gaedcke, et al.. (2019). Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites. EBioMedicine. 40. 394–405. 24 indexed citations
16.
Wang, Xin, Feda H. Hamdan, Robyn Laura Kosinsky, et al.. (2019). ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells. Clinical Epigenetics. 11(1). 92–92. 40 indexed citations
17.
Hamdan, Feda H., Vijayalakshmi Kari, Julia Kitz, et al.. (2019). Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer. Cancers. 11(8). 1142–1142. 14 indexed citations
18.
Schneider, D., Robert Lorenz Chua, Feda H. Hamdan, et al.. (2019). The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells. Clinical Epigenetics. 11(1). 98–98. 26 indexed citations
19.
Nagarajan, Sankari, Upasana Bedi, Feda H. Hamdan, et al.. (2016). BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cells. Nucleic Acids Research. 45(6). gkw1276–gkw1276. 24 indexed citations
20.
Hamdan, Feda H. & Malek Zihlif. (2014). Gene expression alterations in chronic hypoxic MCF7 breast cancer cell line. Genomics. 104(6). 477–481. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole P. Ho Breakdown of academic impact, for papers by Ru Ji Breakdown of academic impact, for papers by Yong Gu Breakdown of academic impact, for papers by Byul A Jee Breakdown of academic impact, for papers by Yu Yin Breakdown of academic impact, for papers by Zhuoying Lin Breakdown of academic impact, for papers by Veerabrahma Pratap Seshachalam Breakdown of academic impact, for papers by Monica Aasrum Breakdown of academic impact, for papers by Tamer Yağcı Breakdown of academic impact, for papers by Haiyan Yue
Rankless by CCL
2026